e2v Launches Colour Versions of Its Market Leading ELiiXA+ Line Scan Cameras

e2v, a leading global provider of high performance imaging solutions, has launched colour versions of its market leading ELiiXA+ line scan cameras.The new colour 16k/8k and 8k/4k cameras are based on e2v's multi-line CMOS technology.They provide users with a true colour mode, making them ideal for high resolution document scanning and the inspection of printing, flat panel displays, printed circuit boards, food, pharmaceutical and high quality raw material surfaces.
e2v has designed it's ELiiXA+ camera family specifically to provide advanced speed, supreme sensitivity and high resolution.This is done by incorporating an innovative CMOS pixel architecture, combining the most advanced signal to noise ratio per individual pixel with multi-line architecture, to boost sensitivity by sequentially integrating the same object line with full exposure control. The family was launched in 2011 with the 16k pixel monochrome camera (for advanced machine vision applications), followed by the 8k/4k pixel monochrome camera in 2012 (broadening the range of applications).
The two new ELiiXA+ colour cameras provide high line rates, up to 95,000 lines per second, and combine high response with an extremely low noise level; this delivers a high signal to noise ratio, even when short integration times are required or when illumination is limited.The 5m pixel size is arranged in four active lines and a dual line filter configuration allows the cameras to be operated in several modes:

• True colour mode with 10m RGB pixels to provideequivalent colour fidelity to 10m pixel tri-linear solutions withadvanced immunity to web variation.
• Full definition mode with a unique 16,384 RGB pixel resolution.

The16k/8k pixel resolution model is available with a CoaXPress interface, whilst the 8k/4k model is interfaced through Camera Link.
Sebastien Teysseyre, e2v's marketing manager for industrial cameras, said "The e2v multi-line CMOS technology available in the ELiiXA+ camera family has been quickly adopted by the market because of its unique capability to simultaneously deliver advanced performance combined with high levels of versatility for system integration.Adding these two new colour models to the ELiiXA+ family supports the market in the ever increasing need for colour imaging, setting new standard for industrial imaging."
The two new colour cameras will be commercially available from May 2013 and will be demonstrated at the Automation World 2013 show in Seoul, Korea (March 13th-16th 2013) and the Vision China show in Shanghai, China (March 19th-March 21th 2013) on e2v partner booths.
Company Logo
http://release.media-outreach.com/release.php/Images/695
NOTES FOR EDITORS
About e2v
e2v is a leading global provider of specialist technology for high performance systems and equipment; delivering solutions, sub-systems and components for applications within medical & science, aerospace & defence, and commercial & industrial markets.
e2v employs approximately 1650 people, has design and operational facilities across Europe, North America and Asia, and has a global network of sales and technical support offices. For the year ended 31 March 2012, e2v reported sales of GBP235m and is listed on the London Stock Exchange.
For more information visit e2v.com

PRESS OFFICE CONTACT:
Fleishman-Hillard Japan
Naoto Yoshida
Email: Email Contact
Tel: +81.3.6204.4364

Source:
e2v Launches Colour Versions of Its Market Leading ELiiXA+ Line Scan Cameras

See also:

The Price of Dr. Allens Device Compares Favorably to BPH Medications Costs Declared in Recent JAAPA Survey, Highlights Fine Treatment
The article in JAAPA dated March 05, 2013, describes BPH medications available and their prices, for instance, Alpha blockers monthly cost for the starting dose on average $70 and 5-ARIs price for the...

Qualify for Instant Bad Credit Auto Loans Without Any Upfront Payment at Valley Auto Loans
Upfront payment is no longer a necessity to receive some of the most lucrative bad credit auto loans for consumers with a problematic credit history. Valley Auto Loans, the most reputed auto loan...

CITIC Securities Selects Advent to Support Growth Strategy
Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services for the global investment management industry, today announced that CITIC Securities Co., Ltd. a leading full-service...

MYL, AVNR and ACT -- Pre-Market Briefing

The Dow Jones and the S&P 500 finished at multi-year highs on Tuesday. The Dow Jones closed 0.39% higher at 14,035.67, the S&P 500 closed 0.73% higher at 1,530.94, and the NASDAQ closed 0.68% higher at 3,213.59. At the close, our research team took notice of Mylan Inc. (NASDAQ: MYL), Avanir Pharmaceuticals (NASDAQ: AVNR) and Actavis Inc. (NYSE: ACT). Wall Street Active research team has completed free research on MYL, AVNR and ACT. As a leading provider of free in depth reports and timely market updates, we invite you to sign up now at
http://www.wallstreetactive.com/register.php
Mylan's Shares Slip
Mylan's shares fell on Tuesday, ending the day 0.38% lower at $29.11 on volume of 2.99 million. The stock rose to a 52-week high of $29.30 before paring its gains. The company's shares have had a decent run so far this year, gaining more than 6% as compared to a gain of around 6.4% for NASDAQ. Mylan's shares recently broke through $29 resistance level, which is a bullish signal. The bullish trend is further confirmed by the recent volume activity and its MACD chart. The stock's MACD is trading above the signal line and the zero-line. Mylan's share are trading above their 50-day and 200-day moving averages, which is another bullish signal. Sign up today and get useful insight about MYL for free at
http://www.wallstreetactive.com/register.php
Avanir Pharma's Shares Gain
Shares of Avanir Pharma, which is engaged in the development and commercialization of therapeutic products for the treatment of central nervous system disorders, rose sharply on Tuesday, ending the day 2.14% higher at $2.86 on volume of 1.07 million. The stock has had a decent run this year, gaining more than 9%. Avanir's shares are trading at their 50-day moving average and slightly below their 200-day moving average. The stock's MACD is currently trading below the signal line and the zero-line. The company's shares are currently facing resistance at around $3.20. The stock has support at $2.80. Free report on AVNR can be accessed by registering at
http://www.wallstreetactive.com/register.php
Actavis Shares End Marginally Lower
Actavis shares finished marginally lower on Tuesday. The stock closed 0.50% lower at $84.81 on above average volume of 2.06 million. Year-to-date, the company's shares have fallen more than 1.3%. The stock has been extremely volatile in recent weeks. It has been facing stiff resistance at around $88. Recent volume activity suggests that the market sentiment is bearish on the stock. The bearish trend is further confirmed by the MACD chart. The stock's MACD has just moved below the signal line and the zero-line. Register with Wall Street Active and download the research on ACT for free at
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com

Source:
MYL, AVNR and ACT -- Pre-Market Briefing

See also:

OSC Approves Release of Academy's Shares from Escrow
ACADEMY EXPLORATIONS LIMITED ("Academy" or the "Company"). On August 31, 2012, the Ontario Securities Commission approved the Company's request in Ontario to amend an existing escrow agreement among...

Danbel Ventures Appoints Ernst & Young LLP as Auditors
Danbel Ventures Inc. ("Danbel" or the "Company") is pleased to announce the appointment of Ernst & Young LLP ("E&Y") as its auditors, replacing Collins Barrow Toronto LLP ("Collins Barrow")....

Global Food Exchange and IFS Fund Announces Its Founders Will Be Presenting at the Accredited Members Spring Micro Cap Investor Conference in Las Vegas
Global Food Exchange Founder, Richard Lackey, and IFS Fund Founder, John Schiffner, will be presenting at the Accredited Members Spring Small Cap/Micro Cap Conference, being held at the JW Marriott...

Gerovital Offers Exciting Line Of Anti-Aging Product

Gerovital, a line of anti-aging medicines and skin creams, has been praised by users all over the world for its ability to fight the signs of aging and restore youthful vitality.

Gerovital